InvestorsHub Logo

mkaiz

12/23/13 11:56 AM

#11414 RE: mkaiz #11413

If you look at (avxl) anavex their alzhiemers medicine 2-73 isn't any more promising than bapi or ponezumab, and they are trading at .25 cents ilns has bigger and more promising pipeline in my opinion